In Vitro Activity of Isavuconazole against Rasamsonia Species

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6890-6891. doi: 10.1128/AAC.00742-16. Print 2016 Nov.

Abstract

The in vitro susceptibilities to the novel triazole isavuconazole and six other antifungal agents of a large collection of Rasamsonia isolates (n = 47) belonging to seven species were determined. Isavuconazole and voriconazole had no in vitro activity (MIC, >32 mg/liter) against isolates of the Rasamsonia argillacea species complex. The echinocandins were the most potent antifungal drugs against all of the isolates tested (minimum effective concentration, ≤0.19 mg/liter).

MeSH terms

  • Antifungal Agents / pharmacology
  • Echinocandins / pharmacology
  • Eurotiales / drug effects*
  • Eurotiales / isolation & purification
  • Humans
  • Microbial Sensitivity Tests
  • Nitriles / pharmacology*
  • Pyridines / pharmacology*
  • Triazoles / pharmacology*

Substances

  • Antifungal Agents
  • Echinocandins
  • Nitriles
  • Pyridines
  • Triazoles
  • isavuconazole

Grants and funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.